Abstract
Motivated by the challenge of risk assessment in a heterogeneous population and guided by advances in our knowledge of the pathobiology of cardiovascular diseases (CVD), basic and clinical scientists have maintained substantial interest in the development and application of novel biomarkers for risk stratification of CVD. In particular, strategies to identify and combine multiple biomarkers, which may reflect diverse pathobiological contributors to the onset and complications of CVD, have been arising as an approach to improve more effectively the risk assessment and target therapy. Moreover, comparative evaluations of novel markers are necessary to estimate these candidates for integration into present and future strategies. In this review we consider the recent in-depth knowledge and advances with the use of systemic biomarkers in the area of CVD with special attention on inflammatory markers and those that can predict an individual arteriosclerotic disease stage.
Keywords: Cardiovascular disease, systemic biomarkers, diagnosis, prognosis, atherosclerosis, risk prediction, risk factors, coronary heart disease, inflammation
Current Molecular Medicine
Title: Novel Systemic Cardiovascular Disease Biomarkers
Volume: 10 Issue: 2
Author(s): G. A. Bonaterra, S. Zugel and R. Kinscherf
Affiliation:
Keywords: Cardiovascular disease, systemic biomarkers, diagnosis, prognosis, atherosclerosis, risk prediction, risk factors, coronary heart disease, inflammation
Abstract: Motivated by the challenge of risk assessment in a heterogeneous population and guided by advances in our knowledge of the pathobiology of cardiovascular diseases (CVD), basic and clinical scientists have maintained substantial interest in the development and application of novel biomarkers for risk stratification of CVD. In particular, strategies to identify and combine multiple biomarkers, which may reflect diverse pathobiological contributors to the onset and complications of CVD, have been arising as an approach to improve more effectively the risk assessment and target therapy. Moreover, comparative evaluations of novel markers are necessary to estimate these candidates for integration into present and future strategies. In this review we consider the recent in-depth knowledge and advances with the use of systemic biomarkers in the area of CVD with special attention on inflammatory markers and those that can predict an individual arteriosclerotic disease stage.
Export Options
About this article
Cite this article as:
Bonaterra A. G., Zugel S. and Kinscherf R., Novel Systemic Cardiovascular Disease Biomarkers, Current Molecular Medicine 2010; 10 (2) . https://dx.doi.org/10.2174/156652410790963330
DOI https://dx.doi.org/10.2174/156652410790963330 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Prophylaxis of Cancer
Current Cancer Therapy Reviews A Review of Medicinal Plant Patents
Recent Patents on Biomedical Engineering (Discontinued) Reperfusion Therapies in Acute Ischemic Stroke
Recent Patents on CNS Drug Discovery (Discontinued) Polycystic Ovary Syndrome in Adolescents
Current Women`s Health Reviews Hematopoietic Growth Factors Support in the Elderly Cancer Patients Treated with Antiblastic Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Novel Biomarkers for Risk Stratification and Identification of Lifethreatening Cardiovascular Disease: Troponin and Beyond
Current Cardiology Reviews Recent Updates on Current and Upcoming Biomarkers for Cardiovascular Diseases
Current Pharmaceutical Design Plant Polyphenols and Oral Health: Old Phytochemicals for New Fields
Current Medicinal Chemistry Meet Our Section Editor
Current Vascular Pharmacology Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments
Current Medicinal Chemistry The Missed Tc-99m Radiopharmaceuticals for Cardiac Imaging
Current Radiopharmaceuticals Chitosan as a Dietary Supplement for Weight Loss: A Review
Current Nutrition & Food Science Patent Selections
Recent Patents on Cardiovascular Drug Discovery Cardiac Monitoring in Patients with Syncope: Making that Elusive Diagnosis
Current Cardiology Reviews Nutrigenomics and Its Approaches for Control of Chronic Diseases
Current Biotechnology Psychological Stress in Pathogenesis of Essential Hypertension
Current Hypertension Reviews Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure
Current Drug Targets HDL-Targeting Therapeutics: Past, Present and Future
Current Pharmaceutical Design Molecular Dissection of Renal Ischemia-Reperfusion: Oxidative Stress and Cellular Events
Current Medicinal Chemistry Traditional and Alternative Therapies for Refractory Angina
Current Pharmaceutical Design